chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Extreme fatigue; Low grade flu symptoms; Vertigo; Dizziness; Vision effected; This is a spontaneous report from a contactable consumer, patient. A 54-year-old non-pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8732) via an unspecified route of administration in the left arm on 27Mar2021 at 11:30 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included hydrochlorothiazide (HTCZ) (MANUFACTURER UNKNOWN), bimatoprost (LATISSE), magnesium (MANUFACTURER UNKNOWN), commiphora mukul, piper longum, terminalia bellirica, terminalia chebula (TRIPHALA GUGGULU), melissa officinalis extract and origanum vulgare extract (MELATON). The patients had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient had not received any other vaccines within four weeks prior to the COVID vaccine. On 27Mar2021 at 15:00 after 4.5 hours post shot, the patient experienced extreme fatigue, then low-grade flu symptoms. The patient felt like she was coming down with something. It was reported as two days out, the patient experienced vertigo, dizziness and vision was affected. The events vertigo and dizziness had continued till 30Mar2021 (third day). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not received treatment for the reported events. The clinical outcome of the events fatigue, low-grade symptoms, vertigo, dizziness and vision affected were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
erythema macule (2x8cm with swelling and tenderness at injection site Treated ->observation.
On Oct. 22, I got the second dose of SHINGRIX in my left arm. I was fine for a few weeks. About a month later, I started having bad shoulder pain in my left arm and slightly less pain in the right shoulder. Then I became very very achy, all over, unable to do any chores. I had hand and foot pain, finger swelling, inability to sleep because of the pain. I no longer can sleep on either side. This is very obviously related to the SHINGRIX shot, because I was fine previous to getting it. I still, today, on Jan. 10 cannot move my left arm out to the side without pain. It feels like the muscle has been weakened somehow. My fingers swell at night and get achy. I cannot wear my rings anymore. It is strange that these reactions are delayed, so long after the shot in October.
Patient's temperature was 103 degrees.  Patient became unresponsive and his eyes rolled back.  Mom called our office and then 911.  Patient transferred to local hospital and discharged home.
Nausea, vomiting, diarrhea, headache, fatigue, lightheadedness, chest tightness, warm red patch on arm
This spontaneous report was received from an administrator, concerning multiple unspecified patients of an unknown age and gender. The patients' medical history, concurrent conditions, concomitant medications, drug reactions or allergies were not reported. On an unspecified date, the patients were vaccinated with an improperly stored dose of ROTATEQ lot # reported as M043836 and expiration date on 14-MAY-2018 (strength and dose were not reported), administered orally for prophylaxis. The storage temperature was 32 to 35 degrees Fahrenheit (°F) (0 to 1 degrees Celsius (°C)) for a time frame of 24 hours with multiple temperature excursions for a total cumulative time frame of 720 hours (dates between 02-MAR-2017 and 30-MAY-2017). Data logger was involved but no adverse effects were reported. This is one of several reports received from the same source. No product quality complaint (PQC) was involved. Additional information has been requested. Sender's Comments: US-009507513-1706USA011485: US-009507513-1706USA011490: US-009507513-1706USA011487: US-009507513-1706USA011488: US-009507513-1706USA011489: US-009507513-1706USA011484: US-009507513-1706USA002362.
This spontaneous report as received from a registered nurse refers to a 12 month old female patient who had 2 siblings. On 30-APR-2013 the patient was vaccinated subcutaneously in the right thigh with a first dose of VARIVAX (lot # H018457, exp. date: 05-OCT-2017). On 09-MAY-2013, almost 10 days after giving vaccine, the patient developed a quarter-sized red, raised spot. His mom stated it felt hot. This was the third reaction like this in this lot of vaccine. There was no illness at time of vaccination. There were no pre-existing allergies, birth defects and medical conditions. The outcome of the events was reported as recovered on "10-SEP-2013". This is one several reports received from the same source. Additional information has been requested.
fainted right away, pale, sweaty, eyes closed and then rolling back in the head.  This never happened before.
Has a fever of 100.2 -100.4 started last night. Lethargic, given Tylenol.
This spontaneous report as received from a master of science in nursing (MSN) refers to a patient of unknown age and gender who on 20-MAR-2013 was vaccinated with VARIVAX (Merck) 5 ml, subcutaneous (route and application site unspecified) (lot # H012506 exp date 25-JUN-2013). The reporter stated that the patient was vaccinated with an improperly VARIVAX (Merck) dose. No adverse effect was reported. This is one of several cases from the same reporter. Additional information has been requested.
Fatigue, mild body ache, headache.  Diarrhea 20 hours later.
Pt. was given a duplicate dose of MMR vaccine & Varicella vaccine. No adverse event with exception of site redness.
1JUN93 a few hrs p/vax pt temp went up to 103; also had high pitched screaming cry x 3-4 hrs; no response to APAP; was seen in ER by MD; remained fretful; treated for ear & throat infect;
Patient developed temperature, does not remember exact number. had trouble with confusion, fatigue and dizziness. 2 days after vaccination was admitted to the hospital and diagnosed with viral meningoencephalitis. Continues to suffer with weakness of the extremities, mental acuity is not as sharp, not able to return to work yet.
Fever 100.6 for 24 hours, muscle aches, chills, headache
Exacerbation of neck pain (due to whiplash), & elevated liver enzymes w/sx related to liver involvement. Pain & tingling down rt arm w/tingling in rt hand & difficulty writing. Nausea, fatigue, joint pain.
Respiratory distress, chest tightness, cyanosis of lips and face, loss of consciousness started <2min after administration of vaccine and lasted until Epinephrine was administered. Approximate duration <7min.
A report was received from a health care professional on 12/19/03 concerning six children of unknown sex and less than 4 years of age who inadvertently received Fluvirin on an unspecified date in December 2003. On an unspecified date in December 2003, the vaccinees inadvertently received Fluvirin. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Mom discovered child had rash when undressed to bath him.  Pruritic skin rash, with redness, hives starting on extremities, but encompassing face by arrival to E.R. at 9:21PM.  Urticaria skin rash involved trunk.  No respiratory involvement, no cough, no fever.
Mild Shingles outbreak 6/26/2021, diagnosed on 6/29/2021 by  Dr.  Took Valtrex 1 gm, 3x/day for a week.  It?s fine now.
This spontaneous report was received from a physician refers to a male patient of unknown age who on an unknown date, was scheduled to receive a dose of GARDASIL (dose and route not reported). It was reported that the patient received a blood draw during his office visit and at some point during the visit the patient fainted and suffered a seizure. It was unspecified if the patient had actually received GARDASIL. At the time of the report, the patient's outcome was unknown. The relatedness for fainted and seizure and GARDASIL was unknown. Upon internal review seizure was considered to be medically significant. Additional information is not expected.
OB stated she should hold off on getting the second dose; first vaccine back in March; found out she was pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (OB stated she should hold off on getting the second dose) and EXPOSURE DURING PREGNANCY (first vaccine back in March; found out she was pregnant) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 06-Mar-2021, the patient experienced EXPOSURE DURING PREGNANCY (first vaccine back in March; found out she was pregnant). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (OB stated she should hold off on getting the second dose). On 06-Mar-2021, EXPOSURE DURING PREGNANCY (first vaccine back in March; found out she was pregnant) had resolved. At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (OB stated she should hold off on getting the second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication were not reported  Treatment medication were not reported Additional information: Second dose was scheduled on April 2nd and the patient wanted to knew whether she can administer the 2nd dose of vaccine   Most recent FOLLOW-UP information incorporated above includes: On 15-Jun-2021: Significant Follow up information includes:Reporter details, patient details and new event was added
Rash all over my body that looks like chicken pox, which started in my hair. I have a bad patch between my breasts. It itches horribly. Severely tired. My body, especially my ears and face, have this feeling of being on fire occasionally. Stomach upset with diarrhea that hits suddenly. Horrible headache. Skin is extremely itchy and dry. I cannot think.  Memory loss.
trying to get second dose of moderna COVID-19 vaccine/received the first dose on 04Jul2021; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (trying to get second dose of moderna COVID-19 vaccine/received the first dose on 04Jul2021) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 3002539) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (trying to get second dose of moderna COVID-19 vaccine/received the first dose on 04Jul2021). At the time of the report, PRODUCT DOSE OMISSION ISSUE (trying to get second dose of moderna COVID-19 vaccine/received the first dose on 04Jul2021) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient is trying to get second dose of moderna COVID-19 vaccine, but they received the first dose in another country and wants to know if it is okay to give it. since the Lot number 3002539 (expiration date 24Oct2021)  came back as invalid on the Lot look up. Wants to know if the dose is the same in another country  No concomitant medications were reported.  No treatment information was provided.
This spontaneous report as received on 14-JUL-2017 from a pharmacist refers to an elderly 72 year old female patient. The patient's medical history, concurrent conditions and concomitant therapy were not reported. On an unknown date, "2 or 3 months ago" the patient had received PNEUMOVAX 23 (Dose, route of administration, site of administration, Lot number and expiration date were not reported.) for prophylaxis.  The pharmacist reported that the patient, on 14-JUL-2017, received another dose of PNEUMOVAX 23 (Lot # N010106, expiration date 15-NOV-2018) (Dose, route of administration, and site of administration were not reported) for prophylaxis. No adverse effects reported. No further information was provided. Product quality complaint was not involved. Additional information has been requested.
Hives - entire body - rx; benadryl Q4H - took for 2 days.
pt recvd vax 11APR95 & 24APR95 pt devel a vesicular rash over trunk & neck w/itching;vesicles were disseminated & fluid filled;also had a sore & dry throat;seen by family MD & recovered by 31APR95
Asthma; I got sick to my stomach and was throwing; I got sick to my stomach and was throwing; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 72-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 11Dec2022 as dose 5 (booster), single (Lot number: GH9697) for covid-19 immunisation. The patient's relevant medical history included: "blood pressure" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: BNT162b2 (DOSE 1, SINGLE, Lot number: EL9264), administration date: 01Apr2021, when the patient was 70-year-old, for COVID-19 immunization, reaction(s): "First two shots, I fell and had hard time getting up Fall"; BNT162b2 (DOSE 2, SINGLE, Lot number: EW0171), administration date: 29Apr2021, when the patient was 70-year-old, for COVID-19 immunization, reaction(s): "I fell and had hard time getting up"; BNT162b2 (DOSE 3 (BOOSTER), SINGLE, Lot number: 0308D), administration date: 10Dec2021, when the patient was 71-year-old, for COVID-19 immunization, reaction(s): "I got sick to my stomach and was throwing up", "I got sick to my stomach and was throwing up"; BNT162b2 (DOSE 4 (BOOSTER), SINGLE, Lot number: FJ4991), administration date: 12Apr2022, when the patient was 71-year-old, for COVID-19 immunization, reaction(s): "I got sick to my stomach and was throwing up", "I got sick to my stomach and was throwing up". The following information was reported: ABDOMINAL DISCOMFORT (non-serious), VOMITING (non-serious) all with onset 11Dec2022, outcome "unknown" and all described as "I got sick to my stomach and was throwing"; ASTHMA (non-serious), outcome "unknown". Therapeutic measures were not taken as a result of asthma, abdominal discomfort, vomiting.  Additional information: The patient had adverse reaction to the first two shots and all three boosters. And then on the other ones, afterwards, couple of hours later, the patient got sick to stomach and was throwing up and those were not given as any of the side effects. The patient did not undergo any investigations. Sender's Comments: Linked Report(s): PFIZER INC-202201375592 same reporter/patient, different vaccine dose;
raised rash on injection site; raised rash on injection site; Warmth at injection site; Swelling of left arm; This spontaneous case was reported by a patient and describes the occurrence of PERIPHERAL SWELLING (Swelling of left arm), VACCINATION SITE RASH (raised rash on injection site), VACCINATION SITE SWELLING (raised rash on injection site) and VACCINATION SITE WARMTH (Warmth at injection site) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included LEVETIRACETAM (KEPRA) for an unknown indication.    On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 14-Apr-2021, the patient experienced PERIPHERAL SWELLING (Swelling of left arm), VACCINATION SITE SWELLING (raised rash on injection site) and VACCINATION SITE WARMTH (Warmth at injection site). On 15-Apr-2021, the patient experienced VACCINATION SITE RASH (raised rash on injection site). At the time of the report, PERIPHERAL SWELLING (Swelling of left arm), VACCINATION SITE RASH (raised rash on injection site), VACCINATION SITE SWELLING (raised rash on injection site) and VACCINATION SITE WARMTH (Warmth at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021: Significant follow up appended
Fever; bodyaches; chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (bodyaches), CHILLS (chills) and PYREXIA (Fever) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036A21A and 007M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included GABAPENTIN and ACETYLSALICYLIC ACID (ASPRIN) for an unknown indication.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced PAIN (bodyaches) and CHILLS (chills). On 05-Mar-2021, the patient experienced PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and ACETYLSALICYLIC ACID (ASPRIN) at an unspecified dose and frequency. At the time of the report, PAIN (bodyaches), CHILLS (chills) and PYREXIA (Fever) outcome was unknown.            concomitant medication provided was blood pressure medication, ZYRTEC.   This case was linked to MOD-2021-037906 (Patient Link).
Dizziness; excessive tiredness; fever of 101F; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), FATIGUE (excessive tiredness) and PYREXIA (fever of 101F) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Nov-2021 at 11:00 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Nov-2021, the patient experienced DIZZINESS (Dizziness), FATIGUE (excessive tiredness) and PYREXIA (fever of 101F). On 28-Nov-2021, DIZZINESS (Dizziness), FATIGUE (excessive tiredness) and PYREXIA (fever of 101F) had resolved.            No concomitant medications were reported.  Treatment information was not provided. The onset of symptoms was around 07:00 AM in the morning. Patient had a fever of 101 degree Fahrenheit.
throwing up tightness in chest tightness in throat elevated heart rate light headed(felt like he would pass out) uncontrollable shaking pale redness of neck dizziness sweating
unauthorized age received vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (unauthorized age received vaccine) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: PFIZER BIONTECH COVID-19 VACCINE (2nd dose) and PFIZER BIONTECH COVID-19 VACCINE (1st dose). Past adverse reactions to the above products included No adverse reaction with PFIZER BIONTECH COVID-19 VACCINE and PFIZER BIONTECH COVID-19 VACCINE.    On 15-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Dec-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (unauthorized age received vaccine). On 15-Dec-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (unauthorized age received vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment medications were reported.
This spontaneous reports as received from a doctor of pharmacy refers to a 72 year old female patient. The patient was vaccinated with a 0.5 ml dose of PNEUMOVAX23 (Lot # reported as H01066, exp 02-FEB-2012, route not reported) on 10-OCT-2012. No other co-suspects were reported. No concomitant medications were reported. In October 2012, the patient was evaluated in the emergency room and was diagnosed with severe bursitis and arthritis. The location on of bursitis and arthritis was unknown. No treatment information was reported. The outcome of the events was not reported. The relationship between the events and PNEUMOVAX23 was not reported. This is one of several reports from the same source. Additional information has been requested.
At 1:45 pm I got the pfizer booster in the middle of lunch. At 4:00pm i started getting pale, progressed to brain fog (feeling drunk), facial drooping on right side, and slurred speech. This lasted until about 7:30 or 8 pm when I recovered almost as fast as I declined, as if it never happened. During the ?episode? I could not drive but was consciously aware that I was in that condition
Vaccines had an expiration date of 03/27/2022. This specific lot number had been taken out of the freezer beginning of March. No cases of adverse reactions have been reported.
Sore injected arm after first primary shot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore injected arm after first primary shot) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced VACCINATION SITE PAIN (Sore injected arm after first primary shot). On 21-Feb-2021, VACCINATION SITE PAIN (Sore injected arm after first primary shot) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medications were reported.  Treatment information was not provided.   This case was linked to MOD-2022-557549, MOD-2022-557681, MOD-2022-557682 (Patient Link).
tested positive for COVID; a little sluggish; lost his taste; felt fatigued; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested positive for COVID), SLUGGISHNESS (a little sluggish), AGEUSIA (lost his taste) and FATIGUE (felt fatigued) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced SLUGGISHNESS (a little sluggish), AGEUSIA (lost his taste) and FATIGUE (felt fatigued). On 16-Jan-2021, the patient experienced COVID-19 (tested positive for COVID). At the time of the report, COVID-19 (tested positive for COVID), SLUGGISHNESS (a little sluggish), AGEUSIA (lost his taste) and FATIGUE (felt fatigued) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Jan-2021, SARS-CoV-2 test positive: positive (Positive) Tested positive for COVID.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medication was reported. Treatment information was not provided.   Reporter did not allow further contact
More severe Headaches, chest tightness, blurry vision, blood shot eyes, stomach pain, back pain, leg pain (back of knees, dizziness off balance.
Day 2 post vaccine SOB and Chest tightness, resolved Day 3 post vaccine L facial numbness Patient called clinic at 4:30 Day 3 post vaccine and was advised to go to ER, pt did not go Day 6 post vaccine patient had office visit and MD advised pt to go to ER for further work up